The relationship between ADHD and obesity: Implications for therapy

Expert Review of Neurotherapeutics

Volumn 14, Issue 5, 2014, Pages 473-479

  Cortese, Samuele ^a,b   Castellanos, F Xavier ^c,d  

^a CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c NEW YORK UNIVERSITY CHILD STUDY CENTER   (United States)

^d NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

Author keywords

attention deficit hyperactivity disorder; diet; psychostimulants; weight; weight management

Indexed keywords

ATTENTION DEFICIT DISORDER; CLINICAL EFFECTIVENESS; COMORBIDITY; HUMAN; MEDICAL RESEARCH; OBESITY; REVIEW; WEIGHT CONTROL; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BIBLIOGRAPHIC DATABASE; COMPLICATION; STATISTICS AND NUMERICAL DATA;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; DATABASES, BIBLIOGRAPHIC; HUMANS; OBESITY;

EID: 84899077977     PISSN: 14737175     EISSN: 17448360     Source Type: Journal    
DOI: 10.1586/14737175.2014.904748     Document Type: Review

References (59)

1. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders. Fifth Edition, DSM-5 American Psychiatric Publishing; Washington, DC: USA: 2013
2. Biederman J, Faraone SV. Attention-deficit hyperactivity disorder. Lancet 2005;366: 237-48
3. Lecendreux M, Cortese S. Sleep problems associated with ADHD: a review of current therapeutic options and recommendations for the future. Expert Rev Neurother 2007;7:1799-806
4. Willcutt EG, Doyle AE, Nigg JT, et al. Validity of the executive function theory of attention-deficit/hyperactivity disorder: a meta-analytic review. Biol Psychiatry 2005;57:1336-46
5. Polanczyk G, de Lima MS, Horta BL, et al. The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry 2007;164:942-8
6. Polanczyk GV, Willcutt EG, Salum GA, et al. ADHD prevalence estimates across three decades: an updated systematic review and meta-regression analysis. Int J Epidemiol 2014;In press; DOI: 0.1093/ije/dyt261
7. Faraone SV, Biederman J, Mick E. The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies. Psychol Med 2006;36: 159-65
8. Simon V, Czobor P, Balint S, et al. Prevalence and correlates of adult attention-deficit hyperactivity disorder: meta-analysis. Br J Psychiatry 2009;194: 204-11
9. Doshi JA, Hodgkins P, Kahle J, et al. Economic impact of childhood and adult attention-deficit/hyperactivity disorder in the United States. J Am Acad Child Adolesc Psychiatry 2012;51:990-1002
10. Le HH, Hodgkins P, Postma MJ, et al. Economic impact of childhood/adolescent ADHD in a European setting: the Netherlands as a reference case. Eur Child Adolesc Psychiatry 2013;In press]; DOI: 10.1007/s00787-013-0477- 8
11. Pliszka S. Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 2007;46:894-921
12. Taylor E, Dopfner M, Sergeant J, et al. European clinical guidelines for hyperkinetic disorder - first upgrade. Eur Child Adolesc Psychiatry 2004;13(suppl 1)):17-30
13. National Institute of Clinical Excellence. Diagnosis and management of ADHD in children, young people and adults. The British Psychological Society and The Royal College of Psychiatrists, Leicester. 2009
14. Castells X, Ramos-Quiroga JA, Rigau D, et al. Efficacy of methylphenidate for adults with attention-deficit hyperactivity disorder: a meta-regression analysis. CNS Drugs 2011;25:157-69
15. Koesters M, Becker T, Kilian R, et al. Limits of meta-analysis: methylphenidate in the treatment of adult attention-deficit hyperactivity disorder. J Psychopharmacol 2009;23:733-44
16. Schachter HM, Pham B, King J, et al. How efficacious and safe is short-acting methylphenidate for the treatment of attention-deficit disorder in children and adolescents? A meta-analysis. CMAJ 2001;165:1475-88
17. van der Oord S, Prins PJ, Oosterlaan J, Emmelkamp PM. Efficacy of methylphenidate, psychosocial treatments and their combination in school-aged children with ADHD: a meta-analysis. Clin Psychol Rev 2008;28:783-800
18. Faraone SV, Biederman J. Efficacy of Adderall for attention-deficit/ hyperactivity disorder: a meta-analysis. J Atten Disord 2002;6:69-75
19. Castells X, Ramos-Quiroga JA, Bosch R, et al. Amphetamines for Attention Deficit Hyperactivity Disorder (ADHD) in adults. Cochrane Database Syst Rev 2011; CD007813
20. Tanaka Y, Rohde LA, Jin L, et al. A meta-analysis of the consistency of atomoxetine treatment effects in pediatric patients with attention-deficit/ hyperactivity disorder from 15 clinical trials across four geographic regions. J Child Adolesc Psychopharmacol 2013;23:262-70
21. Cheng JY, Chen RY, Ko JS, Ng EM. Efficacy and safety of atomoxetine for attention-deficit/hyperactivity disorder in children and adolescents-meta- analysis and meta-regression analysis. Psychopharmacology (Berl) 2007;194: 197-209
22. Kratochvil CJ, Milton DR, Vaughan BS, Greenhill LL. Acute atomoxetine treatment of younger and older children with ADHD: a meta-analysis of tolerability and efficacy. Child Adolesc Psychiatry Ment Health 2008;2:25
23. Cunill R, Castells X, Tobias A, Capella D. Atomoxetine for attention deficit hyperactivity disorder in the adulthood: a meta-analysis and meta-regression. Pharmacoepidemiol Drug Saf 2013;22: 961-9
24. Sonuga-Barke EJ, Brandeis D, Cortese S, et al. Nonpharmacological interventions for ADHD: systematic review and meta-analyses of randomized controlled trials of dietary and psychological treatments. Am J Psychiatry 2013;170:275-89
25. Qureshi IA, Mehler MF. Towards a 'systems'-level understanding of the nervous system and its disorders. Trends Neurosci 2013;36:674-84
26. Cortese S, Vincenzi B. Obesity and ADHD: clinical and Neurobiological Implications. Curr Top Behav Neurosci 2012;9:199-218
27. Cortese S, Faraone SV, Bernardi S, et al. Adult attention-deficit hyperactivity disorder and obesity: epidemiological study. Br J Psychiatry 2013;203:24-34
28. Haslam DW, James WP. Obesity. Lancet 2005;366:1197-209
29. Wang H, Wang J, Liu MM, et al. Epidemiology of general obesity, abdominal obesity and related risk factors in urban adults from 33 communities of Northeast China: the CHPSNE study. BMC Public Health 2012;12:967
30. Wang Y, Lobstein T. Worldwide trends in childhood overweight and obesity. Int J Pediatr Obes 2006;1:11-25
31. Wang YC, McPherson K, Marsh T, et al. Health and economic burden of the projected obesity trends in the USA and the UK. Lancet 2011;378:815-25
32. Popkin BM, Slining MM. New dynamics in global obesity facing low- and middle-income countries. Obes Rev 2013; 14(suppl 2):11-20
33. Young-Hyman D, Tanofsky-Kraff M, Yanovski SZ, et al. Psychological status and weight-related distress in overweight or atrisk-for-overweight children. Obesity (Silver Spring) 2006;14:2249-58
34. Cortese S, Ramos-Olazagasti M, Klein R, et al. Obesity in Men With Childhood ADHD: a 33-Year Controlled, Prospective, Follow-up Study. Pediatrics 2013;131: e1731-8
35. Cortese S, Isnard P, Frelut ML, et al. Association between symptoms of attentiondeficit/hyperactivity disorder and bulimic behaviors in a clinical sample of severely obese adolescents. Int J Obes (Lond) 2007;31:340-6
36. Hart CN, Larose JG, Fava JL, et al. The association between time in bed and obesity risk in young adults. Behav Sleep Med 2013;11:321-7
37. Taheri S, Lin L, Austin D, et al. Short sleep duration is associated with reduced leptin, elevated ghrelin, and increased body mass index. PLoS Med 2004;1:e62
38. Kirov R, Brand S. Sleep problems and their effect in ADHD. Expert Rev Neurother 2014;14:287-99
39. Cortese S, Brown TE, Corkum P, et al. Assessment and management of sleep problems in youths with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 2013;52:784-96
40. Owens J, Gruber R, Brown T, et al. Future research directions in sleep and ADHD: report of a consensus working group. J Atten Disord 2013;17:550-64
41. Cortese S, Konofal E, Dalla BB, et al. Does excessive daytime sleepiness contribute to explaining the association between obesity and ADHD symptoms? Med Hypotheses 2008;70:12-16
42. Byrd HC, Curtin C, Anderson SE. Attention-deficit/hyperactivity disorder and obesity in US males and females, age 8-15 years: National Health and Nutrition Examination Survey 2001-2004. Pediatr Obes 2013;8:445-53
43. Dubnov-Raz G, Perry A, Berger I. Body mass index of children with attentiondeficit/hyperactivity disorder. J Child Neurol 2011;26:302-8
44. Altfas JR. Prevalence of attention deficit/hyperactivity disorder among adults in obesity treatment. BMC Psychiatry 2002;2:9
45. National Institute of Health. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults-The Evidence Report. National Institutes of Health. Obes Res 1998; 6(suppl 2):51S-209S
46. Pagoto SL, Curtin C, Bandini LG, et al. Weight loss following a clinic-based weight loss program among adults with attention deficit/hyperactivity disorder symptoms. Eat Weight Disord 2010;15:e166-72
47. Kessler RC, Adler L, Ames M, et al. The World Health Organization Adult ADHD Self-Report Scale (ASRS): a short screening scale for use in the general population. Psychol Med 2005;35:245-56
48. Nicolau J, Ayala L, Frances C et al. Frequency of attention-deficit/ hyperactivity disorder (ADHD) in a bariatric post surgery sample: clinical, analytical and psychological differences among bariatric patients with ADHD criteria. Endocrine Abstracts 2013;32 p. P777
49. Cook BG, Li D, Heinrich KM. Obesity, Physical Activity, and Sedentary Behavior of Youth With Learning Disabilities and ADHD. J Learn Disabil 2014;In press; DOI: 10.11777/0022219413518582
50. Kim J, Mutyala B, Agiovlasitis S, Fernhall B. Health behaviors and obesity among US children with attention deficit hyperactivity disorder by gender and medication use. Prev Med 2011;52:218-22
51. Docet MF, Larranaga A, Perez Mendez LF, Garcia-Mayor R. Attention deficit hyperactivity disorder increases the risk of having abnormal eating behaviours in obese adults. Eat Weight Disord 2012;17:e132-6
52. Nazar BP, Pinna CM, Suwwan R, et al. ADHD Rate in Obese Women With Binge Eating and Bulimic Behaviors From a Weight-Loss Clinic. J Atten Disord 2012;In press; DOI: 10.1177/1087054712455503
53. Waring ME, Lapane KL. Overweight in children and adolescents in relation to attention-deficit/hyperactivity disorder: results from a national sample. Pediatrics 2008;122:e1-6
54. Byrd HC, Curtin C, Anderson SE. Attention-deficit/hyperactivity disorder and obesity in US males and females age 8-15 years: National Health and Nutrition Examination Survey 2001-2004. Pediatr Obes 2013;8:445-53
55. Levy LD, Fleming JP, Klar D. Treatment of refractory obesity in severely obese adults following management of newly diagnosed attention deficit hyperactivity disorder. Int J Obes (Lond) 2009;33:326-34
56. Ward MF, Wender PH, Reimherr FW. The Wender Utah Rating Scale: an aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder. Am J Psychiatry 1993;150:885-90
57. Cortese S, Holtmann M, Banaschewski T, et al. Practitioner review: current best practice in the management of adverse events during treatment with ADHD medications in children and adolescents. J Child Psychol Psychiatry 2013;54:227-46
58. Verbeken S, Braet C, Goossens L, van der Oord S. Executive function training with game elements for obese children: a novel treatment to enhance self-regulatory abilities for weight-control. Behav Res Ther 2013;51:290-9
59. Anderson DA, Wadden TA. Treating the obese patient. Suggestions for primary care practice. Arch Fam Med 1999;8:156-67